Active	Status	Sponsor type	Region	Phase	Filter
9 Active 1 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

9 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zhao, David
TARGET BP I, NCT02910414 / 2016-002545-32: Clinical Trial	Active, not recruiting	3	300	US	Dehydrated alcohol, Ethanol, Peregrine System Kit (Sham Procedure)	Ablative Solutions, Inc.	Hypertension	12/23	05/26
NCT03735667: ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement	Active, not recruiting	N/A	1948	Canada, US	ACURATE neo2™ Transfemoral TAVR System, Medtronic CoreValve TAVR System, Edwards SAPIEN 3 TAVR System, ACURATE Prime™ Transfemoral TAVR System XL	Boston Scientific Corporation	Aortic Stenosis	06/24	09/34
NCT05149755: Evolut™ EXPAND TAVR II Pivotal Trial	Recruiting	N/A	650	Europe, Canada, Japan, US, RoW	Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT)	Medtronic Cardiovascular	Moderate Aortic Valve Stenosis	02/26	12/34
Gilotra, Nisha
REBIRTH, NCT05180773: Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy	Recruiting	4	250	US	Bromocriptine, Parlodel, Cycloset, Placebo, Guideline Directed Medical Therapy for Heart Failure (GDMT), Rivaroxaban, Xarelto, Second Placebo	Dennis M. McNamara, MD, MS, National Heart, Lung, and Blood Institute (NHLBI)	Peripartum Cardiomyopathy, Postpartum	06/26	12/28
REPAIR-CS, NCT06660732: Rilonacept in Subjects with Cardiac Sarcoidosis	Recruiting	2	60	US	Rilonacept, KPL-914	Mayo Clinic, Johns Hopkins University	Cardiac Sarcoidosis	11/26	03/27
NCT05149755: Evolut™ EXPAND TAVR II Pivotal Trial	Recruiting	N/A	650	Europe, Canada, Japan, US, RoW	Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT)	Medtronic Cardiovascular	Moderate Aortic Valve Stenosis	02/26	12/34
Resar, John
NCT05149755: Evolut™ EXPAND TAVR II Pivotal Trial	Recruiting	N/A	650	Europe, Canada, Japan, US, RoW	Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT)	Medtronic Cardiovascular	Moderate Aortic Valve Stenosis	02/26	12/34
Solet, Darrell
NCT05149755: Evolut™ EXPAND TAVR II Pivotal Trial	Recruiting	N/A	650	Europe, Canada, Japan, US, RoW	Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT)	Medtronic Cardiovascular	Moderate Aortic Valve Stenosis	02/26	12/34
Czarny, Matthew
NCT05149755: Evolut™ EXPAND TAVR II Pivotal Trial	Recruiting	N/A	650	Europe, Canada, Japan, US, RoW	Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT)	Medtronic Cardiovascular	Moderate Aortic Valve Stenosis	02/26	12/34